RE:TBP HaltDELLicious wrote: So, here's a crazy theory. TBP halted earlier today. They have two DINs with Health Canada already. And they announced that they're expecting 'accelerated approval' from FDA for their two drugs CAUMZ and QUIXXLEF by February. But that's not what typically causes a halt. It must be something else, right?
TBP's current market cap is app. $109 million. APHA already owns 20% of TBP. And APHA is closing the $100 million 'strategic investment' tomorrow. Should be more than enough to get the majority ownership of TBP and still have some $$ left to invest into TBP's production of their drugs.
Carl Merton is a APHA's CFO and is on TBP's BOD.
Too many coincidences? Or not? What do you think?
They are in the midst of a 'bought deal' but that should not cause a halt. I would say probably not, to Aphria buying TBP, but your theory isn't that crazy. I would give it a solid 'maybe".